Global Bioresorbable Polymers Market to Reach USD 867.2 Million by 2029, Growing at 11.6% CAGR
核心洞察
The global bioresorbable polymers market is projected to grow from USD 500.0 million in 2024 to USD 867.2 million by 2029, at a CAGR of 11.6%.
Growth is driven by rising surgical interventions, demand for biocompatible devices, and adoption of bioresorbable materials in orthopedic and drug delivery applications.
PLGA is the largest and fastest-growing polymer type, while drug delivery is the fastest-growing application segment.
The global bioresorbable polymers market is projected to grow from USD 500.0 million in 2024 to USD 867.2 million by 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period, according to a report from MarketsandMarkets. Growth is driven by the increasing number of surgical interventions, rising demand for biocompatible medical devices, and growing adoption of bioresorbable materials in orthopedic devices and drug delivery applications.
Bioresorbable polymers are a class of polymers designed to naturally degrade and be absorbed within biological environments. They are utilized in the medical and healthcare sectors to manufacture orthopedic devices and drug delivery systems, and their demand is influenced by innovation in medical devices and the need for eco-friendly alternatives to permanent implants. The key components of this material class include polylactic acid (PLA) (搜索), polyglycolic acid (PGA) (搜索), polylactic-co-glycolic acid (PLGA) (搜索), and polycaprolactone (PCL) (搜索).
Segment Analysis
By type, PLGA is projected to be both the largest and fastest-growing segment, supported by its biocompatibility, biodegradability, and controlled degradation characteristics. An analyst perspective notes that PLGA is expected to remain a key growth area because its degradation rate can be engineered by adjusting its composition.
By application, drug delivery is expected to register the fastest growth due to increasing demand for controlled and sustained drug-release systems. Orthopedic devices remain a major application, driven by demand for implants that provide temporary support while naturally degrading.
Regional Outlook
North America represents a major market for bioresorbable polymers, supported by demand for orthopedic devices and advanced drug delivery technologies. Asia Pacific is expected to register the highest growth, driven by increasing healthcare expenditure, expanding pharmaceutical and medical device industries, and a growing geriatric population. India is identified as the fastest-growing market in the region.
Japan Market Dynamics
Japan's bioresorbable polymers market is valued at USD 18.7 million in 2024, with a projected CAGR of 11.9% through 2029, reaching USD 32.7 million by the forecast end. Japan's advanced healthcare system and robust pharmaceutical sector provide strong adoption drivers for bioresorbable polymers in medical devices and surgical implants. The country's rapidly aging demographic creates sustained demand for innovative medical solutions, while a strong emphasis on minimally invasive procedures drives adoption in drug delivery systems and surgical applications.
Key Industry Trends and Competitive Landscape
Key industry trends include rising adoption of bioresorbable orthopedic implants, increasing demand for controlled drug delivery systems, growing use of 3D printing and electrospinning, development of patient-specific medical devices, increasing focus on biocompatibility and controlled degradation, and expansion of advanced healthcare infrastructure in Asia Pacific. Advances in polymer technology, electrospinning, and 3D printing are further creating opportunities for patient-specific and minimally invasive medical solutions.
Leading companies are focusing on product launches, acquisitions, and capacity expansions to strengthen their positions. Key players include Corbion (搜索), Evonik Industries AG, Foster Corporation (搜索), KLS Martin Group (搜索), DSM Biomedical (搜索), Ashland Global Holdings (搜索), Zeus Company (搜索), Seqens (搜索), Reva Medical (搜索), and Poly-Med Incorporated (搜索).